ADAPTIMMUNE LTD

OX4 2HN (South East)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£2,154,221

Jan 14 - Dec 16

Clinical Development of an Adoptive T cell Therapy for Triple Negative Breast Cancer

Innovate UK award to ADAPTIMMUNE LTD

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}